Matthew Robbins, MD: Residency During COVID-19

July 9, 2020

The director of the Neurology Residency Program at Weill Cornell Medicine provided insight on the experience residents have had during the COVID-19 pandemic and how it has shaped them for the future.

“The neurology that emerges from this will teach them [not just] about what COVID-19 can do, but what other disorders can do as well.”

Throughout the COVID-19 pandemic, doctors, clinicians, and medical professionals at all levels have been thrust into uncomfortable roles and asked to adapt to a climate that is just as unfamiliar. The same has been the case for residents, who are inexperienced to some extent and did not initially expect to handle a pandemic in the early days of their careers.

Matthew Robbins, MD, assistant professor, and director, Neurology Residency Program, Weill Cornell Medicine, shared insight from his experience throughout the pandemic as well as in his role as an overseer of residents at the 2020 American Headache Society (AHS) Annual Meeting. Robbins went on to commend his residents, claiming that this learning experience will be like none other and may offer them a unique chance to take on hard lessons.

In an interview with NeurologyLive, Robbins details how his residents handled the pandemic, and explained the long-term benefits an experience such an this can provide them.